Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$116.17 - $194.55 $261,266 - $437,542
-2,249 Closed
0 $0
Q2 2021

Aug 09, 2021

SELL
$130.4 - $225.58 $110,709 - $191,517
-849 Reduced 27.4%
2,249 $499,000
Q1 2021

May 13, 2021

BUY
$124.11 - $190.17 $101,025 - $154,798
814 Added 35.64%
3,098 $409,000
Q4 2020

Feb 08, 2021

BUY
$112.16 - $174.14 $256,173 - $397,735
2,284 New
2,284 $396,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.78B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Bp PLC Portfolio

Follow Bp PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bp PLC, based on Form 13F filings with the SEC.

News

Stay updated on Bp PLC with notifications on news.